SIBN News and Press, SI-BONE Inc. From 11/06/23

SI-BONE Inc. (SIBN) is expected to report $-0.33 for Q3 2023

SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Jefferies London Healthcare Conference in...

SANTA CLARA, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2023 after market close on Monday, Nov...

SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company focused on sacropelvic surgical solutions, today confirmed that certain CD Horizon® Solera® 5.5mm and 6.0mm posterior spinal fixation rods manufactured by ...

2023-09-04 12:21:00 ET Needham sees the medtech sector growing by 7% in 2023 versus 5.7% last year, despite slowed growth in Q2, helped by double-digit growth in certain cardiology categories. The investment bank noted that medtech growth slowed slightly in Q2, expanding by only 8.3% co...

2023-08-31 16:28:34 ET Summary SI-BONE, Inc. presents compelling long-term value with robust growth in unit economics, high gross profits, and attractive valuation upside. Q2 FY'23 showed record-breaking sales of $33.3 million, with 31% growth in the U.S. market and 5th consecutiv...

SANTA CLARA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Morgan Stanley 21st Annual Global Healthc...

2023-08-07 21:40:06 ET SI-BONE, Inc. (SIBN) Q2 2023 Earnings Conference Call Aug 7, 2023 4:30 PM ET Company Participants Saqib Iqbal - Senior Director, FP&A and Investor Relations Laura Francis - Chief Executive Officer Anshul Maheshwari - Chief Financial Off...

2023-08-07 16:54:09 ET SI-BONE press release ( NASDAQ: SIBN ): Q2 GAAP EPS of -$0.30 beats by $0.10 . Revenue of $33.3M (+30.1% Y/Y) beats by $1.95M . Shares +4.48% . Based on the strength of performance in the second quarter of 2023, SI-BONE is increas...

SANTA CLARA, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended June 30, 2023. Recent Highlights Record wo...